Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: non-traditional factors may play a role in clinical practiceAnna Maria Frustaci, Lara Crucitti, Luana Schiattone et al.|Haematologica|2025Cited by 2
POSTER: CLL-347 Venetoclax Therapy in Chronic Lymphocytic Leukemia Patients Relapsed After Allogeneic Hematopoietic Stem Cell TransplantationFrancesca Perutelli, Marta Coscia, Elia Boccellato et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0
CLL-347 Venetoclax Therapy in Chronic Lymphocytic Leukemia Patients Relapsed After Allogeneic Hematopoietic Stem Cell TransplantationFrancesca Perutelli, Marta Coscia, Elia Boccellato et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0
Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantationFrancesca Perutelli, Marta Coscia, Elia Boccellato et al.|British Journal of Haematology|2025Cited by 0